RESOLUTION ON NEW ISSUE OF SHARES
On November 1, 2007, the Board of Directors in Scandinavian Clinical Nutrition i Sverige AB (SCN) resolved to issue new shares in SCN in connection with the planned listing of the company’s shares on Oslo Axess. On November 5, 2007, the Board resolved that the subscription price shall be 12,90 NOK (approximately 15,30 SEK) and that the subscription period will last from November 6 to November 15, with the right for the Board to extend the period.
On the extraordinary general meeting on October 29, 2007, The Board of SCN was given a mandate to issue new shares. With reference to its mandate, the Board resolved to offer maximum 3 million shares at an indicative price range of NOK 12-16 per share (approximately 14-19 SEK). On November 5, 2007, The Board of SCN resolved that the subscription price shall be 12,90 NOK (approximately 15,30 SEK), It was also decided that the subscription period will last from November 6 to November 15, with the right for the Board to extend the period. The issuance is primarily addressed to investors on the Norwegian market, but is open for all.
From November 6 to November 15, 2007, the company will be out on a roadshow to meet with investors.
Please refer to the press release regarding the issuance that was published November 2, 2007.
For further information:
Ulf Söderberg, CEO, ulf.soderberg@scnutrition.com, +46 708 13 22 81
Anders Struksnes, Senior Vice President, anders.struksnes@scnutrition.com, +47 911 98 942
Scandinavian Clinical Nutrition AB (publ) works in R&D and sales of scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as CUUR, Membraseven, Coldizin, Immulina and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and scientifically documented products, create the right conditions for profitable growth both in Sweden and in the company’s export markets. The SCN share is listed for trade on NGM Nordic MTF since December 6, 2006.